BMN-111

vosoritide · BioMarin Pharmaceutical

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BMN-111, covering 2012-06-11 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia [Phase 2]